Bristol Myers Squibb Reports Positive Results for CAR T-Cell Therapy in Heavily Pretreated Multiple MyelomaByQuincy AttobrahSeptember 8th 2026
Etentamig Improves Responses and Progression-Free Survival in Relapsed Multiple MyelomaBySpencer FeldmanSeptember 3rd 2026
6 Cancer Drugs FDA Approved in August 2026 and What They Mean for YouBySpencer FeldmanSeptember 2nd 2026
FDA Approves Zenbexus Combination for Patients With Multiple Myeloma After Prior TreatmentBySpencer FeldmanAugust 13th 2026